Delivery Order SPE2DB20D1100-SPE2DB25FC0Y4
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Voranigo 40 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $54,189.90 and employs firm fixed pricing, with an ultimate completion date of September 16, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and...
- The Defense Logistics Agency awarded a delivery order valued at $27,094.95 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on May 30, 2025, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement action reflecting the contractor's capability to fulfill federal pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for supply of Voranigo 40 mg tablets (30-count packages) with a ceiling value of $27,094.95. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 16, 2025. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Voranigo 40 mg tablets (30-count packages) with a ceiling value of $54,189.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 19, 2025, with performance based at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among qualified vendors in the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $27,094.95. The delivery order was competitively awarded without set-aside designations on August 21, 2025, with an ultimate completion date of September 12, 2025. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, serves as the place of performance for this...
- The Defense Logistics Agency (DLA) awarded a $27,094.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on September 17, 2025, with an ultimate completion date of October 8, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $27,094.95 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) on October 8, 2025, with completion scheduled for October 30, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a specific pharmaceutical procurement fulfilling military healthcare supply requirements...
- The Defense Logistics Agency awarded a $108.4K delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Voranigo 40 mg tablets (30-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of October 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract, indicating it was competitively awarded through open competition. This delivery...
- The Defense Logistics Agency awarded a $54,189.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Voranigo 40 mg tablets (30-count units), with an ultimate completion date of October 3, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $27,094.95 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) on August 25, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC0Y4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $54,189.90. The contract, which became effective on May 2, 2025, with an ultimate completion date of May 23, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, leveraging its established role as a primary pharmaceutical distributor for federal medical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026. This comprehensive pharmaceutical support vehicle enables AmerisourceBergen to supply a wide range of medications and medical supplies to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. The company's selection for this and similar federal contracts reflects its demonstrated capability to meet competitive federal procurement requirements and serve as a critical vendor for specialized pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $54.2k | 5/2/25 |